GOJO Introduces New PROVON Antimicrobial Foam Handwash

Article

GOJO Industries, a leading global producer and marketer of skin health and hygiene solutions and the inventors of PURELL™, announces the introduction of its latest formulation, PROVON® Antimicrobial Foam Handwash with 2% Chlorhexidine Gluconate (CHG). This new formulation is one of the most effective and gentle soap formulations GOJO has launched into the healthcare market to date.

This new formulation, which exceeds the FDA Healthcare Personnel Handwash requirements, is gentle on hands making it mild enough for everyday use. This non-irritating, hypoallergenic, dermatologist-tested formulation maintains the skin’s natural moisture barrier. PROVON Antimicrobial Foam Handwash with 2% CHG also:

• Is fragrance and dye free
• Leaves hands feeling clean and soft
• Rinses quickly with no sticky, tacky residue
• Is compatible with latex gloves

“We are committed to developing safe and effective hand hygiene products,” said Jeff Hall, healthcare business vice president and general manager, GOJO. “This CHG formulation delivers strong germ kill as well as an unexpected mildness not usually associated with CHG handwashes and surgical scrubs. We know hand hygiene plays a critical role in protecting patient safety and reducing germ transmission, but practicing good hand hygiene can be difficult on your hands when you are not using the right products. This is why we continue to advance the science of hand hygiene and develop products that are efficacious and maintain skin health. This newest formulation is an example of this commitment.”

GOJO offers a full portfolio of safe and effective hand hygiene solutions including antimicrobial and non-antimicrobial soaps and PURELL® Advanced Hand Sanitizer, as well as the world’s largest portfolio of green certified soaps and hand sanitizers, which provides healthcare facilities the benefit of choosing the best hand hygiene solution to meet their needs.

Source: GOJO Industries 

Related Videos
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Chikungunya virus, 3D illustration. Emerging mosquito-borne RNA virus from Togaviridae family that can cause outbreaks of a debilitating arthritis-like disease   (Adobe Stock 126688070 by Dr Microbe)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
Woman lying in hospital bed (Adobe Stock, unknown)
Deborah Birx, MD
Centers for Disease Control and Prevention  (Adobe Stock, unknown)
CDC (Adobe Stock, unknown)
Inside Track with Infection Control Today
Related Content